0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
Correspondence |

Improved Outcomes of Pediatric Dilated Cardiomyopathy and Heart Transplantation FREE

Warren G. Guntheroth, MD
[+] Author Information

Department of Pediatrics (Cardiology), University of Washington School of Medcine, Seattle, WA 98195-6320

American College of Cardiology Foundation

J Am Coll Cardiol. 2005;45(10):1733-1734. doi:10.1016/j.jacc.2005.02.045
Published online

The report by Tsirka et al. (1) provided a very useful update of the outcomes for infants and children who develop dilated cardiomyopathy (DCM). Their use of a category combining death and cardiac transplant (“heart death”) as end points was sensible and helpful. However, some of the diagnostic categories were less than fully explained and somewhat arbitrary. If patients with muscular dystrophy (n = 4) and inherited metabolic disorders (n = 5), both uniformly fatal diseases, were not included, their total population of DCM would be only 82 instead of 91, and the population of survivors with recovery of normal contractility would amount to 40% of that population. This raises a serious question about proceeding to transplantation in the first year of the disease, as four centers have advised on the basis of their perception that DCM had such a poor prognosis. In this published cohort, some recovered as late as six years after onset; would 40% of the transplanted children have recovered with normal contractility had they not been transplanted?

Although the title of their study asserts that transplantation for DCM will provide “improved outcomes,” that can only apply to the first few years after cardiac transplantation, which lasts on average 10 to 13 years. In contrast, 40% of all patients with DCM recovered systolic function without transplantation and were still normal eight years later. The difference between transplants and complete recovery does not take into account the morbidity of rejections and anti-immune treatments for the transplanted patients. If 40% of the transplanted children would have recovered, the overall outcome would certainly not be improved.

Finally, the reliability of separating myocarditis from idiopathic DCM is raised by their finding of no differences between the two groups for either “heart death” or for recovery of function. This important finding throws doubt on the criteria used to diagnose myocarditis.

In sum, this important study by Tsirka et al. (1) provided several important advances in our knowledge, even though the title made promises that were unwarranted.

References

Tsirka  A.E., Trinkaus  K., Chen  S.-C.; Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 44 2004:391-397.
CrossRef | PubMed

Figures

Tables

Interactive Graphics

Video

References

Tsirka  A.E., Trinkaus  K., Chen  S.-C.; Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 44 2004:391-397.
CrossRef | PubMed

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Topics